Table 1 describes our predictions for the change in Glx/NAA and GABA/Glx ratios in ALS patients relative to healthy controls, based on the model presented in section Overview of MRS and Measurement of Glutamate, GABA, and Glutamine in the Presence of Neuronal Loss
Additionally, there are inconclusive results from case-control studies (99101), as well as individual cohort studies (102, 103)
ExpiCHO-S cells were transfected with pCAGGS-AIM with each mutation and cultured in ExpiCHO Expression Medium supplemented with ExpiCHOFeed and ExpiFectamine CHO Enhancer for 4 days in a 37 C incubator with a humidified atmosphere of 8% CO 2 in air on an orbital shaker
Clinical studies have found that using GHK-Cu can improve skin firmness by 20-30% over 12 weeks
Key risks include lean muscle mass loss, heart rate elevation, pancreatitis, gallbladder disease, hypoglycaemia, and acute kidney injury from dehydration